Is Bifidobacterium breveeffective in the treatment of childhood constipation? Results from a pilot study

During the treatment phase intake of study medica- tion, defecation frequency, consistency of stools, pain during defecation, frequency of episodes of faecal incon- tinence,

All patients will be asked to complete a 2-week daily diary recording stool frequency, the consistency of each stool (using the BSFS), worst abdominal pain (on a scale of 0 –

• Secondary outcomes: composite clinical responders after 12 weeks; abdominal pain responders, stool consistency responders, adequate relief responders, frequency of

All patients will be asked to complete a 2-week daily diary recording stool frequency, the consistency of each stool (using the BSFS), worst abdominal pain (on a scale of 0 –

In two randomized trials in adults with irritable bowel syndrome and constipation, and 1 in constipated women with a defecation frequency ⬍ 3 times per week, a significant increase

Conclusion: This study is aimed to show that the fermented dairy product containing Bifidobacterium lactis strain DN-173 010 is effective in increasing stool frequency after 3

Summary of the mean stool frequency and consistency, and indicative digestive tolerance recorded daily by eight volunteers per treat- ment group for each of 14 days in the

The frequency of hard stool defecation, sensation of painful defecation, sensation of incomplete evacuation, sensation of anorectal obstruction, and doing manual maneuver